Skip to content

Based on the vitamin D-mediated TH17/Treg balance mechanism, the clinical role of Kidney Nourishing Fetal Pill in the treatment of endometriosis was studied

Based on the vitamin D-mediated TH17/Treg balance mechanism, the clinical role of Kidney Nourishing Fetal Pill in the treatment of endometriosis was studied

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300077208
Enrollment
Unknown
Registered
2023-11-01
Start date
2023-11-01
Completion date
Unknown
Last updated
2023-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometriosis

Interventions

Control group:placebo+Tangor Women's Decoction Ointment
Experimental group:Kidney nourishing fetal pills+Tangor Women's Decoction Ointment

Sponsors

The First Affiliated Hospital of Heilongjiang University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1.Those who meet the diagnostic standards of Western medicine and Chinese medicine differentiation standards for this disease; 2.Females aged 20-45 years; 3.Those who are able to follow up; 4.Those who voluntarily participated in this research research.

Exclusion criteria

Exclusion criteria: 1.Genital organ cancer or other local or systemic malignant tumors, or genital tuberculosis and malformations; 2.Patients with serious diseases such as cardiovascular and cerebrovascular, liver, kidney and hematopoietic system; 3.dysmenorrhea caused by other causes, primary dysmenorrhea, infertility or pelvic mass, nodules; 4.Patients with adenomyosis or uterine fibroids; 5.Those who receive multiple other treatments at the same time; 6.Those who have received hormonal and related drugs in the past six months or have uncontrolled chronic diseases; 7.Psychological disorders, combined with mental disorders and intellectual disabilities who cannot express their condition; 8.those who do not meet the diagnostic criteria and inclusion criteria, or those with chocolate cysts with a diameter greater than 8 cm; 9.Lactating women, pregnant women, allergic patients.

Design outcomes

Primary

MeasureTime frame
Pelvic cyst size under gynaecological vaginal ultrasound;

Secondary

MeasureTime frame
Visual Analog Scale (VAS) for dysmenorrhea;TCM syndrome score;Relevant blood markers;

Countries

China

Contacts

Public ContactSun Miao

The First Affiliated Hospital of Heilongjiang University of Chinese Medicine

sunmiao82@163.com+86 137 0481 0319

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026